Rockefeller Capital Management L.P.

Position in CLDX — Celldex Therapeutics, Inc.

CIK 1739439 NEW YORK, NY

Position in CLDX

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$48,222

+$11,713 QoQ

Shares Held

1,296

+12.6% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#197

of 252 holders

Holding Since

Sep 2021

9 quarters on record

Voting authority Sole 29% Shared 0% None 71%

Healthcare · as of Jun 30, 2026

Rockefeller Capital Management L.P. holds $307,135,875 across 241 Biotechnology names. CLDX ranks #103 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	149,476	$74,249,211
2	JAZZ	Jazz Pharmaceuticals plc	167,409	$40,340,545
3	ACAD	Acadia Pharmaceuticals Inc	1,015,420	$25,690,124
4	BMRN	Biomarin Pharmaceutical Inc	433,376	$24,797,774
5	PTCT	Ptc Therapeutics, Inc.	302,393	$24,666,195
6	MDGL	Madrigal Pharmaceuticals, Inc.	29,015	$15,579,603
7	REGN	Regeneron Pharmaceuticals, Inc.	21,563	$13,445,391
8	CORT	Corcept Therapeutics Inc	123,388	$10,728,585

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$48,222	1,296	+12.6%	Shares	Defined	2026-08-13
2026-03-31	$36,509	1,151	+400.4%	Shares	Defined	2026-05-14
2025-12-31	$6,246	230	+1110.5%	Shares	Defined	2026-03-17
2025-09-30	$491	19	-48.6%	Shares	Defined	2025-11-14
2022-12-31	$1	37	0.0%	Shares	Defined	2023-03-06
2022-09-30	$1,040	37	0.0%	Shares	Defined	2022-11-02
2022-06-30	$997	37	+8.8%	Shares	Defined	2022-08-12
2021-12-31	$1,313	34	0.0%	Shares	Defined	2022-02-14
2021-09-30	$1,835	34	—	Shares	Defined	2021-11-12
No filing history on record for this holder in this stock.